• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-016
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fistula (1862)
Event Type  Injury  
Manufacturer Narrative
The reported event of aorta¿to¿right atrium fistula could not be confirmed.The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
A literature article titled, transcatheter closure of aorta-to-right atrium fistula caused by erosion of amplatzer septal occluder (jacc cardiovasc interv.2017 feb 27;10(4):e33-e35), reviewed a case of a (b)(6) girl with a 12mm secundum-type atiral septal defect (asd) and a deficient aortic rim underwent successful asd closure using a 16mm amplatzer septal occluder (aso).Follow-up echocardiography 1 month later showed a small aorta¿to¿right atrium fistula.The patient was asymptomatic initially but developed hematuria and fatigue 3 weeks later.Hemoglobin dropped to 9.8 g/dl from 13.4 g/dl.After informed consent was obtained from the patient¿s parents, cardiac catheterization was performed under general anesthesia with fluoroscopic and transthoracic echocardiographic guidance.Aortography showed that the diameter of the fistula was 3 mm.The fistula was crossed in a retrograde fashion from the aorta using a 5-f judkins right coronary catheter.A 0.035-inch glide wire was advanced into the superior vena cava and exteriorized out of the femoral vein.A 6-f patent ductus arteriosus delivery sheath was advanced in an antegrade manner into the ascending aorta.A 6/4mm patent ductus arteriosus device was deployed to close the fistula.The patient is doing well with good device position and no residual leak on echocardiography through 3-year follow-up.Patient weight is not available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key7120210
MDR Text Key94928608
Report Number2135147-2017-00166
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-016
Device Catalogue Number9-ASD-016
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/21/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age7 YR
-
-